Search Results - "Spiro, Timothy"

Management of Atrial Fibrillation in Patients on Ibrutinib: A Cleveland Clinic Experience by Khalid, Sidra, Yasar, Samin, Khalid, Aariez, Spiro, Timothy Pp, Haddad, Abdo, Daw, Hamed

“…Background Ibrutinib is a Bruton's tyrosine kinase inhibitor, which is United States Food and Drug Administration (FDA)-approved for chronic lymphocytic…”
Get full text

Pulmonary toxicities of biologics: a review by Peerzada, Maajid Mumtaz, Spiro, Timothy P, Daw, Hamed A

“…With the advancement of research in cancer treatment more and more drugs are being introduced for the treatment of cancer. In this review study, we have tried…”
Get full text

Pancoast Tumor Secondary to Large Cell Neuroendocrine Carcinoma by Thiruchelvam, Nirosshan, MD, Randhawa, Jaskirat, MD, Daw, Hamed, MD, Spiro, Timothy, MD, Haddad, Abdo, MD

Get full text

Dosage Adjustments for Chemotherapy and Targeted Therapies in Colorectal and Pancreatic Cancer Patients with Hepatic Impairment by Khalid, Sidra, Khalid, Aariez, Clark, Bernadette A, Haddad, Abdo, Spiro, Timothy Pp, Daw, Hamed

“…There are many novel chemotherapeutic options and targeted therapies available for the treatment of colorectal and pancreatic cancer. Patients with these…”
Get full text

Pulmonary toxicities of tyrosine kinase inhibitors by Peerzada, Maajid Mumtaz, Spiro, Timothy P, Daw, Hamed A

“…The incidence of pulmonary toxicities with the use of tyrosine kinase inhibitors (TKIs) is not very high; however, various case reports and studies continue to…”
Get full text

Aromatase Inhibitor–Related Musculoskeletal Symptoms: Is Preventing Osteoporosis the Key to Eliminating These Symptoms? by Muslimani, Alaa A, Spiro, Timothy P, Chaudhry, Asif A, Taylor, Harris C, Do, Ishmael Jaiyesimi, Daw, Hamed A

“…Abstract Background Aromatase inhibitors (AIs) are an effective treatment for postmenopausal women with hormone receptor–positive breast cancer. However,…”
Get full text

Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential by Nihal, Minakshi, Mikkola, Debra, Horvath, Nancy, Gilliam, Anita C, Stevens, Seth R, Spiro, Timothy P, Cooper, Kevin D, Wood, Gary S

“…Cutaneous lymphoid hyperplasia (CLH) has been proposed to be the benign end of a continuum of lymphoproliferative disorders with cutaneous lymphoma at its…”
Get full text

Hepatitis B reactivation in cancer patients: role of prechemotherapy screening and antiviral prophylaxis by Kawsar, Hameem I, Shahnewaz, Jamila, Gopalakrishna, K V, Spiro, Timothy P, Daw, Hamed A

“…Hepatitis B virus (HBV) infection is a potentially life-threatening condition that can be effectively prevented by vaccination. In the United States, more than…”
Get full text

The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma by Muslimani, Alaa A, Farag, Hany L, Francis, Smitha, Spiro, Timothy P, Chaudhry, Asif A, Chan, Vincent C, Taylor, Harris C, Daw, Hamed A

“…In non-Hodgkin lymphomas (NHLs), the bone marrow (BM) involvement is a sign of extensive disease and the iliac crest BM biopsy (BMB) is the established method…”
Get full text

Cerebral nocardiosis in a patient with NHL treated with rituximab by Kundranda, Madappa N., Spiro, Timothy P., Muslimani, Alaa, Gopalakrishna, K.V., Melaragno, Mark J., Daw, Hamed A.

Get full text

Venous thromboembolism in lymphoma: how effectively are we treating patients? by Muslimani, Alaa A, Spiro, Timothy P, Chaudhry, Asif A, Taylor, Harris C, Daw, Hamed A

“…Patients with solid tumors and venous thromboembolic episodes (VTE) have a high risk of recurrence and bleeding during oral anticoagulant treatment. However,…”
Get full text

Venous thromboembolism in patients with monoclonal gammopathy of undetermined significance by Muslimani, Alaa A, Spiro, Timothy P, Chaudhry, Asif A, Taylor, Harris C, Jaiyesimi, Ishmael, Daw, Hamed A

“…Monoclonal gammopathy of undetermined significance (MGUS) is defined by the presence of a serum M-protein at a concentration of 3 g/dL or less, with less than…”
Get full text

A Renal Mass in a Patient With Melanoma by Boughan, Kirsten M, Setrakian, Sebouh, Lee, Chi Hoon, Spiro, Timothy P, Daw, Hamed A

“…Abstract A 61-year-old man presented to the emergency room with significant weight loss. Laboratory analysis revealed elevations in blood urea nitrogen,…”
Get full text

Secondary myelodysplastic syndrome after hydroxychloroquine therapy by Muslimani, Alaa A, Spiro, Timothy P, Chaudhry, Asif A, Daw, Hamed A

“…Primary myelodysplastic syndromes (MDS) occur in the absence of exposure to ionizing radiation, chemotherapeutic agents or myelotoxic drugs, whereas secondary…”
Get full text

Haematuria as an uncommon initial presenting symptom of metastatic squamous cell carcinoma (SCC) to kidney by Kawsar, Hameem I, Spiro, Timothy P, Daw, Hamed A

“…A 47-year-old female presented with a 2-week history of painless haematuria. Urine dipstick showed moderate leucocytes. Blood and urine cultures were negative…”
Get full text

BOOP as a rare complication of gemcitabine therapy by Kawsar, Hameem I, Spiro, Timothy P, Cocco, Amy, Daw, Hamed A

“…Gemcitabine is commonly used in combination with carboplatin in patients with advanced non-small-cell lung cancer (NSCLC). Gemcitabine has good clinical…”
Get full text

Complete Remission of Metastatic Carcinoma of the Prostate with Bicalutamide Withdrawal by Kundranda, Madappa N, Muslimani, Alaa, Daw, Hamed A, Spiro, Timothy P

“…Abstract An 83-year-old man was diagnosed with stage 4 prostate cancer with a Gleason score of 7 (3+4). His Initials prostate-specific antigen (PSA) level was…”
Get full text

5-Fluorouracil-induced cardiotoxicity during chemotherapy for adenocarcinoma of the small bowel by Abou El Fadl, Mohamed H, Bagai, Rajesh K, Spiro, Timothy P, Daw, Hamad A

Get full text

Sequential Tumor Biopsies in Early Phase Clinical Trials of Anticancer Agents for Pharmacodynamic Evaluation by DOWLATI, Afshin, HAAGA, John, REMICK, Scot C, SPIRO, Timothy P, GERSON, Stanton L, LIU, Lili, BERGER, Sosamma J, BERGER, Nathan A, WILLSON, James K. V

“…Purpose : In the setting of target-based anticancer drug development, it is critical to establish that the observed preclinical activity can be attributed to…”
Get full text

Primary Cardiac Sarcoma: 25-Year Cleveland Clinic Experience by Randhawa, Jaskirat S, Budd, George T, Randhawa, Mandeep, Ahluwalia, Manmeet, Jia, Xuefei, Daw, Hamed, Spiro, Timothy, Haddad, Abdo

“…Cardiac sarcomas are rare and have a poor prognosis. The median overall survival remains dismal and has been reported ranging from 6 months to a few years…”
Get full text